17-50699716-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052855.4(ANKRD40):c.461C>T(p.Ser154Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,613,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052855.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD40 | NM_052855.4 | c.461C>T | p.Ser154Leu | missense_variant | 3/5 | ENST00000285243.7 | NP_443087.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD40 | ENST00000285243.7 | c.461C>T | p.Ser154Leu | missense_variant | 3/5 | 1 | NM_052855.4 | ENSP00000285243.6 | ||
ANKRD40 | ENST00000513072.1 | c.227C>T | p.Ser76Leu | missense_variant | 2/2 | 2 | ENSP00000468442.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152202Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000838 AC: 21AN: 250470Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135548
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461202Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 726794
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.461C>T (p.S154L) alteration is located in exon 3 (coding exon 3) of the ANKRD40 gene. This alteration results from a C to T substitution at nucleotide position 461, causing the serine (S) at amino acid position 154 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at